Month: September 2016

Quanta News

Quanta presents interim analysis of first 255 treatments using SC+

Seroba’s investee company, Quanta Dialysis Technologies Ltd (“Quanta” or the “Company”), a medical device company providing innovative haemodialysis solutions for the clinic and the home, today announced that it will present a poster at a moderated session on Friday 23rd September at 11:30am-12:30pm at the 10th International Congress of the International Society of Haemodialysis (ISHD). …

Quanta presents interim analysis of first 255 treatments using SC+ Read More »

Veryan Premarket Approval

Veryan announces first patient enrolment into MIMICS-3D Registry

MIMICS-3D is a prospective, multicentre, observational registry to evaluate the BioMimics 3D Self-Expanding Stent System in the treatment of peripheral arterial disease. The Registry will evaluate safety, effectiveness and device performance within a real-world clinical population in a minimum of 500 patients across Europe. The MIMICS-3D Registry PI, Michael Lichtenberg MD (Arnsberg, Germany) commented: “Having …

Veryan announces first patient enrolment into MIMICS-3D Registry Read More »

T: 353 (0)1 633 4028

18 Herbert Street
Dublin 2
D02 FK19
Ireland

Scroll to Top